HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body's immune system and makes it vulnerable to disease, including ones rarely seen in otherwise ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Gilead Sciences, Inc. GILD announced positive data from its ongoing phase I study evaluating pipeline candidate, lenacapavir.

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

This Is What Happens to the Body When HIV Drugs Are Stopped for Millions of People A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing ...

Now millions of people take drugs known as antiretrovirals that keep HIV from spreading in the body.Stopping those drugs lets the virus start multiplying in the body again, and it could become ...